Shanshan Cai Lab

Publications

  • First author / Co-first author
  • Corresponding author

Research Areas

Immunology, Inflammation & Disease Mechanisms

Research on immune regulation, inflammation, molecular and cellular mechanisms, and disease pathogenesis across cancer and non-cancer conditions.

Disease and Research Areas: Acute lung injury · Viral and infectious diseases · Pulmonary fibrosis · Gout and inflammatory disease · Tumor immunology · Breast cancer · Lung cancer · Colorectal cancer · Multiple sclerosis · Epilepsy · Gastrointestinal disease · Tissue regeneration

  1. Wang X, Nong S, Zheng Q, Zhao C, Yi C, Li S, Zhao L, Kong X, Zhou Y, Dong D, Niu W, Chen Z, Liu C, Zhao W, Sun Z, Wei J, Lv Y, Yang L, Jin X, Cai S*, Wu D, Jiang F. Aerobic exercise pretreatment mitigates acute lung injury through metabolic reprogramming, anti-inflammatory modulation, and 6-keto-prostaglandin F1α regulation. Free Radic Biol Med. 2025;238:550-562. doi:10.1016/j.freeradbiomed.2025.06.024.
  2. Clayton E, Ackerley J, Aelmans M, Ali N, Ashcroft Z, Ashton C, Barker R, Budryte V, Burrows C, Cai S, Callaghan A, Carberry J, Chatwin R, Davies I, Farlow C, Gamblin S, Iacobut A, Lambe A, Lynch F, Mihalache D, Mokbel A, Potamsetty S, Qadir Z, Soden J, Sun X, Vasile A, Wheeler O, Rohaim MA, Munir M. Structural bases of zoonotic and zooanthroponotic transmission of SARS-CoV-2. Viruses. 2022;14(2):418. doi:10.3390/v14020418.
  3. Zou B, Jiang H, Ruan J, Yang D, Chen X, Cai S*, Yi X. Integrative genomics reveals causal pleiotropy and therapeutic opportunities at the interface of acute pancreatitis and infection. J Hepatobiliary Pancreat Sci. 2026;33(3):194-207. doi:10.1002/jhbp.70041.
  4. Funjika E, Colombo SAP, Hayes KS, Tozer MJ, Tyrrell KA, Cai S, Faniyi AA, Shears RK, Dooley M, Alshammari Y, Alhazmi W, Assas M, Almilaibary A, Jackson-Jones LH, Thornton DJ, Worthington JJ, Grencis RK. High-fat diet-induced resistance to helminth infection via alternative induction of type 2 immunity. Mucosal Immunol. 2023;16(1):27-38. doi:10.1016/j.mucimm.2023.01.004.
  5. Xu C, Zhou Z, Lin Y, Zhang S, Cai S*, Li B, Wang Z. Network medicine modeling of the m⁶A regulatory landscape identifies a KLF6-WTAP axis as a therapeutic target in pulmonary fibrosis. J Transl Med. 2026;24(1):439. doi:10.1186/s12967-026-07876-x.
  6. Huang L, Liu J, Zheng X, Zhang K, Chen Y, Chen X, Zhang S, Cai S*, Cai L, Guo Y, Zhu P, Li M. Integrated multi-omics mapping of the causal landscape of gout across the circulating-tissue axis. Front Immunol. 2026;17:1776456. doi:10.3389/fimmu.2026.1776456.
  7. Bai X, Cai S+, Jiang J, Tian M, Du J, Zhao P. Sema7a drives an immunosuppressive microenvironment of breast cancer via Kdm4a-mediated DNA replication regulation. Commun Biol. 2025;9(1):423. doi:10.1038/s42003-025-09327-7.
  8. Xue H, Chen Y, Qi F, Chen K, Liu X, Zhang M, Gao Z, Cai S*, Gao T, Zhang T. The relationship between genetic mutations and organ metastasis in non-small cell lung cancer. Ther Adv Med Oncol. 2026;18:17588359261424770. doi:10.1177/17588359261424770.
  9. Xu C, Li T, Zhang L, Zhang Q, Cai S*, Fu Q, Zhang S. LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses. Neoplasia. 2026;72:101267. doi:10.1016/j.neo.2025.101267.
  10. Xiong Y, Yang D, Cai S*. The predictive, preventive, and personalized medicine of multiple sclerosis: Ferroptosis and circulating proteins. Neurol Res. 2025. doi:10.1080/01616412.2025.2541908.
  11. Zhang D, Zhang Q, Li G, Yu L, Ma Y, Hong X, Kui Y, Cai S*, Sun J, Zhu Z. Integrative genomic and spatial transcriptomic analysis elucidates the oligodendrocyte-mediated etiology of epileptic cortical thinning. Epilepsia Open. 2026. doi:10.1002/epi4.70251.
  12. Lv Y, Gong W, Li L, Li Z, Fu JN, Zhi F, Cai S*. Resveratrol alleviates functional dyspepsia-like pathology by modulating chemokine- and cytokine-related immune–epithelial signaling in the duodenal mucosa. Front Immunol. 2026;17:1906024. doi:10.3389/fimmu.2026.1906024.
  13. Hu C, Yang G, Xiong H, Xie Y, Yuan Z, Liu J, Wang P, Li M, Xu J, Li Q, Li C, Han W, Peng X, Zhang L, Cai S*, Zhong F, Dai L, Liu S, Xia Z. From germline variants to tumor outcome: GWAS-based functional genomics prioritizes colorectal cancer susceptibility genes and links SMAD9 to prognosis. Hum Mutat. 2026;2026:5617762. doi:10.1155/humu/5617762.
  14. Niu X, Pan R, Xiong J, Liao X, Mao X, Xu R, Ye S, Cai S*, Xing H. Constructing Schottky junctions in PCL scaffolds: NIR triggers photo-electricity-catalysis coupling to promote osteogenic differentiation and antibacterial efficacy. Colloids Surf A Physicochem Eng Asp. 2026;735:139497. doi:10.1016/j.colsurfa.2026.139497.

AI, Medical Imaging & Computational Methods

Research developing and applying artificial intelligence, machine learning, deep learning, medical imaging, multimodal data integration, computer vision, predictive modeling, and computational optimization methods.

Disease and Application Areas: Oncology (breast cancer, brain tumors, bone tumors, and pituitary adenomas) · Pneumonia and respiratory imaging · Neurological and neuropsychiatric disorders · Medical image generation · Wearable health and gait analysis · Computer vision · Multimodal imaging · Numerical optimization

  1. Liu Y, Chen J, Yang D, Liu C, Tang C, Cai S*, Huang Y. Machine learning combined with multi-omics to identify immune-related lncRNA signature as biomarkers for predicting breast cancer prognosis. Sci Rep. 2025;15(1):23863. doi:10.1038/s41598-025-10186-9.
  2. Yuan T, Zhang H, Jin J, Chen Z, Cai S*. A novel adaptive Superb Fairy-Wren Optimization Algorithm for solving numerical optimization problems. Biomimetics (Basel). 2025;10(8):496. doi:10.3390/biomimetics10080496.
  3. Yuan Y, Yu Y, Cai S*, Cheng W. Optimizing wearable IMU configurations for running gait analysis: A machine learning-based sensor fusion approach. Front Bioeng Biotechnol. 2026;14:1762919. doi:10.3389/fbioe.2026.1762919.
  4. Zhang R, Cai S*, He Z, Zhao Y. Aerospace aluminum surface defect detection method based on multi-scale convolution and attention mechanism. Sci Rep. 2026;16(1):6428. doi:10.1038/s41598-026-37293-5.
  5. Cai S*. Pneumonia detection in chest X-rays using a YOLOv12n architecture with dynamic feature aggregation. Sci Rep. In press.
  6. Yin Y, Liu H, Cai S*, Ye Y. An enhanced connected banking system optimizer with multiple strategies for numerical optimization problems. Sci Rep. 2026;16(1):12564. doi:10.1038/s41598-026-38261-9.
  7. Zheng R, Cai S*. Brain tumor detection on magnetic resonance imaging scans using the artificial intelligence-based You Only Look Once algorithm. J Int Med Res. 2026;54(3):3000605261422820. doi:10.1177/03000605261422820.
  8. Tang G, Cai S, Meng X, Huo S, Wang M, Lu Z, Chen Z, Luo X. High-fidelity medical image generation: Controllable synthesis of high-resolution medical images via hierarchical fusion in vector-quantized generative networks. Front Phys. 2025;13:1661146. doi:10.3389/fphy.2025.1661146.
  9. Chen C, Yu C, Cai S*. Advancing landslide recognition through multi-dimensional feature fusion and transformer architectures. Vis Comput. 2025;41:11311-11325. doi:10.1007/s00371-025-04108-z.
  10. Liu Y, Cai S+, Liu Y, Guo X, Geng Q, Ling X. PE-Det: Prior-guided visible preconditioning and routed expert fusion for robust infrared-visible object detection. Expert Syst Appl. 2026;321:132275. doi:10.1016/j.eswa.2026.132275.
  11. Jiang M, Cai S+, Zhang K, Li M, Tian Y, Wang T, Alarcón Rodríguez R, Wang Z, Wu S, He J, Yuan Z, Lu L, Lai G, Zhang C, Bo Z, Wei R. Deep learning in medical image analysis for bone tumor: A comprehensive survey. Inf Fusion. 2026;133:104305. doi:10.1016/j.inffus.2026.104305.
  12. Liu S, Dai J, Guo Q, Cao S, Wu C, Zhu C, Li B, Shang A, Cai S*, Yu X, Wang N, Luo Y. Machine learning-based prediction of early visual field nonrecovery after endoscopic surgery for nonfunctioning pituitary adenomas with clinically accessible biomarkers: A dual-center study. Int J Clin Pract. 2026;2026:2504255. doi:10.1155/ijcp/2504255.
  13. Yang J, Wang X, Peng L, Tang J, Cai S*, Xue Y. Agentic artificial intelligence-driven explainable deep learning for deciphering noncoding pathogenic mechanisms of delirium through genomic big data integration. Big Data. 2026;14:280-290. doi:10.1177/2167647X261463929.

Toxicology, Pharmacology & Drug Safety

Research on environmental and chemical toxicology, molecular toxicology, pharmacology, pharmacovigilance, adverse drug reactions, network pharmacology, drug repurposing, therapeutic resistance, and natural products.

Disease and Application Areas: Environmental and chemical exposures · Cardiovascular toxicity · Atherosclerosis · Cardiac hypertrophy · Cancer and carcinogenesis · Chemotherapy and immunotherapy safety · Pulmonary drug toxicity · Hepatobiliary toxicity · Ovarian cancer · Lung cancer · Periodontal disease · Natural products and drug discovery

  1. Li Z, Xie D, Wang T, Wu X, Zhang G, Fu JN, Li S, Cai S*. PAK2 mediates PhIP-induced proliferative and oxidative stress responses in colorectal cancer cells. Chem Biol Interact. 2026;436:112205. doi:10.1016/j.cbi.2026.112205.
  2. Li R, Zheng J, Tang Y, Liu A, Liu J, Cai S*. Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study. Vascul Pharmacol. 2026;162:107589. doi:10.1016/j.vph.2026.107589.
  3. Li G, Long F, Liu Z, Fu JN, Teng Y, Cai S, Zhang X, Wang Y. GAS6 mediates Benzo[a]pyrene-induced pathological cardiac hypertrophy via the mTOR/HIF-1α glycolytic remodeling axis. Chem Biol Interact. 2026. Article 112313. doi:10.1016/j.cbi.2026.112313.
  4. Sun W, Huo S, Li S, Yang D, Wei C, Zheng J, Cai S*. Evaluating the role of glutathione reductase in aspartame-induced liver hepatocellular carcinoma: A molecular network and prognostic approach. Toxicol Lett. 2025;413:111748. doi:10.1016/j.toxlet.2025.111748.
  5. Li G, Jin Y, Yuan X, Wu X, Li L, Liao J, Cai S*. Integrative network toxicology reveals lipoprotein lipase as a key mediator of dibutyl phthalate-associated head and neck squamous cell carcinoma. Food Chem Toxicol. 2026;213:116091. doi:10.1016/j.fct.2026.116091.
  6. Chen Y, Wang C, Jiang P, Chen Y, Zhang T, Cai S*. Comparison of pharmacovigilance and mechanism analysis of the vascular toxicity caused by platin-based chemotherapy: Integration of FAERS analysis, network pharmacology, and endothelial validation. Ther Adv Drug Saf. 2026;17:1-22. doi:10.1177/20420986261454190.
  7. Feng X, An Y, Hou F, Guo Q, Cai S*, Xu H, He Y. Polygonati Rhizoma attenuates oxidative stress-induced senescence in periodontal ligament stem cells. Food Sci Nutr. 2026;14(6):e71672. doi:10.1002/fsn3.71672.
  8. Li C, Ding Y, Cai S+, Liu C, Wang X. Post-marketing safety concerns with tislelizumab: A disproportionality analysis of the FDA adverse event reporting system. Front Immunol. 2025;16:1596842. doi:10.3389/fimmu.2025.1596842.
  9. Li C, Wu C, Cai S*+, Wang L. Pharmacovigilance evidence of drug-induced urinary incontinence in the FDA adverse event reporting system. Sci Rep. 2025;15(1):38278. doi:10.1038/s41598-025-23379-z.
  10. Xu L, Xie X, Cai S, Yang F, Wu G, Wang H. Adverse events associated with the use of nivolumab in the middle-aged and older population (>45 years): A pharmacovigilance analysis based on the FAERS database. Medicine (Baltimore). 2026;105(14):e48180. doi:10.1097/MD.0000000000048180.
  11. Tian X, Zhao Y, Li G, Zhu W, Yang D, Cai S, Li L. Pharmacovigilance signal detection for drug-induced vanishing bile duct syndrome using the FDA Adverse Event Reporting System. Int J Clin Pract. 2026;2026:6035774. doi:10.1155/ijcp/6035774.
  12. Wu W, Zhen H, Li G, Cai S*, Fan X. Systematic pharmacovigilance and genetic validation of medications associated with organizing pneumonia: Integrating FAERS data with multiomics analysis. Int J Clin Pract. 2026;2026:1237587. doi:10.1155/ijcp/1237587.
  13. Yu B, Wang N, Cai S, Yan H, Sun S, Wang S, Li Y, Liang Z. Research progress on peptides that inhibit melanin synthesis. Front Pharmacol. 2025;16:1610623. doi:10.3389/fphar.2025.1610623.
  14. Zhong Y, Cai S+, Fang C, Dai W. Exploring the mechanism of Stephania tetrandra S. Moore in the treatment of cisplatin resistance against ovarian cancer through integration of network pharmacology and molecular docking. Medicine (Baltimore). 2025;104(46):e45860. doi:10.1097/MD.0000000000045860.
  15. Wang N, Wang S, Cai S, Yu B, Lan W. An updated review on the botany, phytochemistry, and pharmacological potential of the genus Caragana. Biochem Syst Ecol. 2026;124:105165. doi:10.1016/j.bse.2025.105165.
  16. Chen Y, Huang X, Ou J, Qi F, Jiang P, Zhang T, Cai S*. Identifying antidiabetic drugs for lung cancer treatment through genetic epidemiology, multiomics integration, and functional validation. Int J Clin Pract. 2026;2026:1363193. doi:10.1155/ijcp/1363193.

Clinical, Epidemiological & Population Health Research

Research using clinical cohorts, population-based datasets, epidemiological methods, evidence synthesis, health behavior research, and public health approaches to investigate disease risk, prognosis, prevention, and health outcomes.

Disease and Population Areas: Mental health · Cardiometabolic disease · Cardiovascular disease · Cirrhosis · Cancer epidemiology · Epilepsy · Radiation exposure · Nutrition and body composition · Musculoskeletal health · Urological health · Patient adherence · Migrant and population health

  1. Wan Z, Cai S*. Mediation roles of oxidative stress, inflammation, and insulin resistance biomarkers in the sitting time-depression association among US adults. J Affect Disord. 2026;401:121326. doi:10.1016/j.jad.2026.121326.
  2. Wan Z, Cai S*. Association between air pollution exposure, physical activity, and risk for cardiometabolic multimorbidity incidence: A cohort study from China. Int J Biometeorol. 2026;70(2):34. doi:10.1007/s00484-025-03122-z.
  3. Lu Y, Liu Y, Cai S*, Xing C. PTAR as a robust independent predictor for malignant arrhythmia and liver-related decompensation in cirrhosis: A retrospective cohort study. Int J Clin Pract. 2026;2026:6298169. doi:10.1155/ijcp/6298169.
  4. Huang B, Lin C, Feng Y, Cai S*, Zhao M, Hu C, Wang L. Association between physical activity domains and cardiovascular diseases among US adults: Evidence from NHANES 2007-2020. Sci Rep. 2025;15(1):35341. doi:10.1038/s41598-025-19419-3.
  5. Luo P, Cai S+, Zhou H, Zhu J, Yang Y, Lian Y. Association between sarcopenia index based on the serum creatinine to cystatin C ratio and cancer incidence in middle-aged and older adults in China: A nationwide cohort study. Nutrition. 2026;145:113084. doi:10.1016/j.nut.2025.113084.
  6. Feng Y, Cai S+, Wang M, Guo Y, Zhou Z, Wang R, Yang S. Efficacy and safety of antioxidants and dietary therapies for epilepsy: An umbrella meta-analysis. Front Nutr. 2026;12:1723370. doi:10.3389/fnut.2025.1723370.
  7. Wang Y, Hassan R, Cai S*, Ghazali L, Zin AABM, Yang S, Zeng L. Micronucleus formation in oral mucosal cells following dental X-ray exposure: A systematic review and meta-analysis. Dentomaxillofac Radiol. 2026;55(3):235-251. doi:10.1093/dmfr/twaf075.
  8. Wang W, Cai S+, Liu K, Luo P. Synergistic effect of long-term L-citrulline supplementation combined with exercise on body composition in adults: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2026;98:103339. doi:10.1016/j.ctim.2026.103339.
  9. Su Z, Yang D, Wang C, Xiao Z, Cai S*. Structural assessment of family and educational influences on student health behaviours: Insights from a public health perspective. PLoS One. 2025;20(9):e0333086. doi:10.1371/journal.pone.0333086.
  10. Li C, Cai S+, Meng Q, Wang N, Liu B, Wang P, Li S. The association between arthritis and the risk of lower urinary tract symptoms suggestive of benign prostate hyperplasia: Evidence from the China Health and Retirement Longitudinal Study. Sci Rep. 2025;15(1):40662. doi:10.1038/s41598-025-28671-6.
  11. Tan X, Cai S+, Kan Y, Xu N, Chen Y, Xu M, Huang D. The impact of perceived usefulness of wearable devices on treatment adherence in fracture patients: The chain mediating roles of self-efficacy and meaning in life. Patient Prefer Adherence. 2026;20:555791. doi:10.2147/PPA.S555791.
  12. Dong B, Hu Q, Zhou Y, Cai S, Li Y, Zhang X. Utilization of public health services and health outcomes among China’s migrant population: An equity analysis. Front Health Serv. 2026;6:1708382. doi:10.3389/frhs.2026.1708382.

Featured Research Focus

Cancer Research

Cancer Research is a cross-cutting research focus spanning cancer biology and the tumor microenvironment, artificial intelligence and medical imaging, cancer therapeutics and drug safety, environmental carcinogenesis, and cancer epidemiology.

Cancer Types and Research Areas: Breast cancer · Lung cancer · Colorectal cancer · Brain tumors · Bone tumors · Head and neck cancer · Liver cancer · Ovarian cancer · Tumor microenvironment · Cancer genomics · Cancer AI · Cancer therapeutics · Drug safety · Environmental carcinogenesis · Cancer epidemiology

Cancer Biology & Tumor Microenvironment

  1. Bai X, Cai S+, Jiang J, Tian M, Du J, Zhao P. Sema7a drives an immunosuppressive microenvironment of breast cancer via Kdm4a-mediated DNA replication regulation. Commun Biol. 2025;9(1):423. doi:10.1038/s42003-025-09327-7.
  2. Xue H, Chen Y, Qi F, Chen K, Liu X, Zhang M, Gao Z, Cai S*, Gao T, Zhang T. The relationship between genetic mutations and organ metastasis in non-small cell lung cancer. Ther Adv Med Oncol. 2026;18:17588359261424770. doi:10.1177/17588359261424770.
  3. Xu C, Li T, Zhang L, Zhang Q, Cai S*, Fu Q, Zhang S. LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses. Neoplasia. 2026;72:101267. doi:10.1016/j.neo.2025.101267.
  4. Hu C, Yang G, Xiong H, Xie Y, Yuan Z, Liu J, Wang P, Li M, Xu J, Li Q, Li C, Han W, Peng X, Zhang L, Cai S*, Zhong F, Dai L, Liu S, Xia Z. From germline variants to tumor outcome: GWAS-based functional genomics prioritizes colorectal cancer susceptibility genes and links SMAD9 to prognosis. Hum Mutat. 2026;2026:5617762. doi:10.1155/humu/5617762.

Cancer Imaging & AI

  1. Liu Y, Chen J, Yang D, Liu C, Tang C, Cai S*, Huang Y. Machine learning combined with multi-omics to identify immune-related lncRNA signature as biomarkers for predicting breast cancer prognosis. Sci Rep. 2025;15(1):23863. doi:10.1038/s41598-025-10186-9.
  2. Zheng R, Cai S*. Brain tumor detection on magnetic resonance imaging scans using the artificial intelligence-based You Only Look Once algorithm. J Int Med Res. 2026;54(3):3000605261422820. doi:10.1177/03000605261422820.
  3. Jiang M, Cai S+, Zhang K, Li M, Tian Y, Wang T, Alarcón Rodríguez R, Wang Z, Wu S, He J, Yuan Z, Lu L, Lai G, Zhang C, Bo Z, Wei R. Deep learning in medical image analysis for bone tumor: A comprehensive survey. Inf Fusion. 2026;133:104305. doi:10.1016/j.inffus.2026.104305.

Cancer Therapeutics & Drug Safety

  1. Chen Y, Wang C, Jiang P, Chen Y, Zhang T, Cai S*. Comparison of pharmacovigilance and mechanism analysis of the vascular toxicity caused by platin-based chemotherapy: Integration of FAERS analysis, network pharmacology, and endothelial validation. Ther Adv Drug Saf. 2026;17:1-22. doi:10.1177/20420986261454190.
  2. Li C, Ding Y, Cai S+, Liu C, Wang X. Post-marketing safety concerns with tislelizumab: A disproportionality analysis of the FDA adverse event reporting system. Front Immunol. 2025;16:1596842. doi:10.3389/fimmu.2025.1596842.
  3. Xu L, Xie X, Cai S, Yang F, Wu G, Wang H. Adverse events associated with the use of nivolumab in the middle-aged and older population (>45 years): A pharmacovigilance analysis based on the FAERS database. Medicine (Baltimore). 2026;105(14):e48180. doi:10.1097/MD.0000000000048180.
  4. Zhong Y, Cai S+, Fang C, Dai W. Exploring the mechanism of Stephania tetrandra S. Moore in the treatment of cisplatin resistance against ovarian cancer through integration of network pharmacology and molecular docking. Medicine (Baltimore). 2025;104(46):e45860. doi:10.1097/MD.0000000000045860.
  5. Chen Y, Huang X, Ou J, Qi F, Jiang P, Zhang T, Cai S*. Identifying antidiabetic drugs for lung cancer treatment through genetic epidemiology, multiomics integration, and functional validation. Int J Clin Pract. 2026;2026:1363193. doi:10.1155/ijcp/1363193.

Carcinogenesis & Environmental Exposures

  1. Li Z, Xie D, Wang T, Wu X, Zhang G, Fu JN, Li S, Cai S*. PAK2 mediates PhIP-induced proliferative and oxidative stress responses in colorectal cancer cells. Chem Biol Interact. 2026;436:112205. doi:10.1016/j.cbi.2026.112205.
  2. Sun W, Huo S, Li S, Yang D, Wei C, Zheng J, Cai S*. Evaluating the role of glutathione reductase in aspartame-induced liver hepatocellular carcinoma: A molecular network and prognostic approach. Toxicol Lett. 2025;413:111748. doi:10.1016/j.toxlet.2025.111748.
  3. Li G, Jin Y, Yuan X, Wu X, Li L, Liao J, Cai S*. Integrative network toxicology reveals lipoprotein lipase as a key mediator of dibutyl phthalate-associated head and neck squamous cell carcinoma. Food Chem Toxicol. 2026;213:116091. doi:10.1016/j.fct.2026.116091.

Cancer Epidemiology & Population Health

  1. Luo P, Cai S+, Zhou H, Zhu J, Yang Y, Lian Y. Association between sarcopenia index based on the serum creatinine to cystatin C ratio and cancer incidence in middle-aged and older adults in China: A nationwide cohort study. Nutrition. 2026;145:113084. doi:10.1016/j.nut.2025.113084.